Skip to main content
. 2018 Jan 10;2018(1):CD001905. doi: 10.1002/14651858.CD001905.pub3

Comparison 12. Intravenous midazolam versus intravenous lorazepam.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Seizure cessation 1 80 Risk Ratio (M‐H, Fixed, 95% CI) 0.98 [0.91, 1.04]
2 Time from drug administration to stopping of seizures 1 80 Mean Difference (IV, Fixed, 95% CI) 1.5 [‐9.37, 12.37]
3 Additional dose of the trial drug required to stop seizures 1 80 Risk Ratio (M‐H, Fixed, 95% CI) 3.0 [0.13, 71.51]
4 Seizure recurrence within 24 hours 1 80 Risk Ratio (M‐H, Fixed, 95% CI) 1.0 [0.15, 6.76]